Licensing Opportunities
The FMI is interested and experienced in the biomedical translation of its research findings.
Please contact the Head Patents and Licensing with questions and comments.
Below is a list of all the published licensing opportunities.
| Title (priority date) | Phosphorylated Twist1 and cancer(30.10.09) |
|---|---|
| Inventors | Xue, Gresko, Vichalkowskiy & Hemmings |
| Title (priority date) | Functionalized organotypic systems (29.09.09) |
| Inventors | Busskamp, Dübel, Picaud, Sahel & Roska |
| Title (priority date) | Treating cancer by modulating MEX-3 (22.09.09) |
| Inventors | Ciosk & Kalchhauser |
| Title (priority date) | Genetic vasectomy by overexpression of PRML- EGFP fusion protein in spermatids (28.08.09) |
| Inventors | Peters, Buch & Pelczar |
| Title (priority date) | Novel therapy for anxiety (06.03.09) |
| Inventors | Caroni, Gogolla, Herry & Lüthy |
| Title (priority date) | Treating cancer by modulating RNA helicases (24.09.2008) |
| Inventors | BENTIRES-ALJ & NAGAMINE |
| Title (priority date) | Modulating XRN2 (04.12.2008) |
| Inventors | Chatterjee & Grosshans |
| Title (priority date) | Treating cancer by modulating a MNK (12.11.2008) |
| Inventors | Grzmil, Hemmings, Merlo & Morin |
| Title (priority date) | Teneurin and cancer (07.11.2008) |
| Inventors | Chiquet & Kenzelmann |
| Title (priority date) | Modulating neuronal plasticity and treatment of neuronal loss by modulating Wnt7a or Wnt7b modulation (04.11.2008) |
| Inventors | Caroni |
| Title (priority date) | Experimental models of non-alcoholic fatty liver disease (31.10.2008) |
| Inventors | Dümmler, Hemmings & Zhuravleva |
| Title (priority date) | Novel mitochondrial dye (25.06.2008) |
| Inventors | Oertner & Rose |
| Title (priority date) | Treating Cancer by Down-Regulating Frizzled-4 and/or Frizzled-1 (11.03.2008) |
| Inventors | Hynes & Schlange |
| Title (priority date) | Novel Tool for the Analysis of Neural Circuits (11.03.2008) |
| Inventors | Balint, Boldogkoi & Roska |
| Title (priority date) | Use of protease nexin 1 inhibitors to reduce metastasis (06.12.2007) |
| Inventors | Fayard & Monard |
| Title (priority date) | Biomarkers for the onset of neurodegenerative diseases (28.11.2007) |
| Inventors | Caroni & Saxena |
| Title (priority date) | Method for prolonging longevity (03.09.2007) |
| Inventors | Adilov, Alcedo & Maier |
| Title (priority date) | Uses and methods relating to NDR kinaseexpression and/or activity (29.11.2006) |
| Inventors | Cornils, Dirnhofer & Hemmings |
| Title (priority date) | Markers and screens (10.8.01) |
| Inventors | Ackermann and Matus |
| Title (priority date) | Anti-tumour agents and methods of identifying anti-tumour agents (9.8.01) |
| Inventors | Chiquet-Ehrismann and Orend |
| Title (priority date) | Tumour-cell specific gene expression and its use in cancer therapy (23.6.00) |
| Inventors | Imbert, Krek and Gallani |
| Title (priority date) | Compound and Method (9.6.00) |
| Inventors | Hemmings and Maira |
| Title (priority date) | Protease-activated receptor (PAR) modulator assays (15.12.99) |
| Inventors | Altrogge and Monard |
| Title (priority date) | Materials and Methods Relating to Cell Motility (20.3.03) |
| Inventors | Badache, Hynes and Marone |
| Title (priority date) | Phosphorylated NDR kinase (26.11.02) |
| Inventors | Bichsel, Hemmings, Stegert and Tamaskovic |
| Title (priority date) | PURIFIED PKB KINASE AND USES THEREOF (13.6.02) |
| Inventors | Feng, Hemmings and Hill |